Supplementary Table 1 from HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table 1. LD50 concentrations of different agents (determined at 48h) are indicated. Also shown are agents used at 10muM.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361909728